Daré Bioscience, Inc.
DARE
$1.75
$0.031.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 110.85% | -183.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 110.85% | -183.46% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 110.85% | 99.07% | |||
| SG&A Expenses | 5.10% | 2.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.47% | -17.36% | |||
| Operating Income | 4.07% | 16.44% | |||
| Income Before Tax | 11.30% | 8.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.30% | 8.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.30% | 8.26% | |||
| EBIT | 4.07% | 16.44% | |||
| EBITDA | 5.27% | 23.86% | |||
| EPS Basic | 38.32% | 9.42% | |||
| Normalized Basic EPS | 38.30% | 9.41% | |||
| EPS Diluted | 38.16% | 9.42% | |||
| Normalized Diluted EPS | 38.30% | 9.41% | |||
| Average Basic Shares Outstanding | 43.78% | 1.28% | |||
| Average Diluted Shares Outstanding | 43.78% | 1.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||